Treatment of Complex Cutaneous Leishmaniasis with Liposomal Amphotericin B.
Maria UbalsPau Bosch-NicolauAdrián Sánchez-MoltalváFernando SalvadorGloria Aparicio-EspañolElena SulleiroAroa SilgadoAntonio Soriano-ArandesMaria EspiauBerta FerrerDiana PouBegoña Treviño MaruriIsrael MolinaVicente García-Patos BrionesPublished in: Pathogens (Basel, Switzerland) (2021)
L-AmB for complex CL showed no treatment failures, offering an alternative treatment option for patients with complex CL. Clinicians should pay close attention to the potential adverse events of L-AmB and adopt an active drug safety surveillance scheme to rapidly detect reversible side effects.